Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Aline Daniele Furlan Pagliotto, Katiany Rizzieri Caleffi-Ferracioli, Mariana Aparecida Lopes, Vanessa Pietrowski Baldin, Clarice Queico Fujimura Leite, Fernando Rogério Pavan, Regiane Bertin de Lima Scodro, Vera Lúcia Dias Siqueira, et al. (9 authors)
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2016-12
Abstract
We report the in vitro drugs interaction by the resazurin drugs combination microtiter assay (REDCA) of amoxicillin (AMO)/clavulanate (CLAV) with isoniazid (INH), ethambutol (EMB), and rifampicin (RIF) against susceptible and resistant Mycobacterium tuberculosis isolates. The addition of AMO/CLAV to classical antituberculosis drugs should be explored as a promising alternative for the treatment of resistant tuberculosis (TB).
MeSH terms
- Amoxicillin
- Antitubercular Agents
- Clavulanic Acid
- Drug Resistance, Multiple, Bacterial
- Ethambutol
- Humans
- Isoniazid
- Microbial Sensitivity Tests
- Mycobacterium tuberculosis
- Oxazines
- Rifampin
- Xanthenes